1. Home
  2. SUPN vs DNUT Comparison

SUPN vs DNUT Comparison

Compare SUPN & DNUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SUPN
  • DNUT
  • Stock Information
  • Founded
  • SUPN 2005
  • DNUT 1937
  • Country
  • SUPN United States
  • DNUT United States
  • Employees
  • SUPN N/A
  • DNUT N/A
  • Industry
  • SUPN Biotechnology: Pharmaceutical Preparations
  • DNUT Food Chains
  • Sector
  • SUPN Health Care
  • DNUT Consumer Staples
  • Exchange
  • SUPN Nasdaq
  • DNUT Nasdaq
  • Market Cap
  • SUPN 1.8B
  • DNUT 505.6M
  • IPO Year
  • SUPN 2012
  • DNUT 2021
  • Fundamental
  • Price
  • SUPN $33.18
  • DNUT $3.33
  • Analyst Decision
  • SUPN Hold
  • DNUT Buy
  • Analyst Count
  • SUPN 2
  • DNUT 8
  • Target Price
  • SUPN $36.00
  • DNUT $10.23
  • AVG Volume (30 Days)
  • SUPN 790.6K
  • DNUT 3.9M
  • Earning Date
  • SUPN 08-05-2025
  • DNUT 08-07-2025
  • Dividend Yield
  • SUPN N/A
  • DNUT 4.20%
  • EPS Growth
  • SUPN N/A
  • DNUT N/A
  • EPS
  • SUPN 1.11
  • DNUT N/A
  • Revenue
  • SUPN $667,997,000.00
  • DNUT $1,597,883,000.00
  • Revenue This Year
  • SUPN N/A
  • DNUT N/A
  • Revenue Next Year
  • SUPN $12.02
  • DNUT $2.80
  • P/E Ratio
  • SUPN $29.94
  • DNUT N/A
  • Revenue Growth
  • SUPN 11.82
  • DNUT N/A
  • 52 Week Low
  • SUPN $26.65
  • DNUT $2.50
  • 52 Week High
  • SUPN $40.28
  • DNUT $12.68
  • Technical
  • Relative Strength Index (RSI)
  • SUPN 60.49
  • DNUT 58.10
  • Support Level
  • SUPN $31.35
  • DNUT $3.22
  • Resistance Level
  • SUPN $33.80
  • DNUT $3.47
  • Average True Range (ATR)
  • SUPN 0.92
  • DNUT 0.20
  • MACD
  • SUPN 0.16
  • DNUT 0.09
  • Stochastic Oscillator
  • SUPN 79.12
  • DNUT 84.18

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

About DNUT Krispy Kreme Inc.

Krispy Kreme Inc is a sweet treat brand company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in-your-mouth experience. It operates through its network of fresh Doughnut Shops, partnerships with retailers, and a growing e-commerce and delivery business. The company conducts its business through the following three reported segments: U.S., which includes all operations in the United States; International, which includes operations in the U.K., Ireland, Australia, New Zealand, Canada, Japan, and Mexico; and Market Development, which includes franchise operations across the globe. It derives maximum revenue from the U.S. segment.

Share on Social Networks: